retatrutide dosing in clinical trials Reta trial data & — a must read (Reta) isn't just another GLP-1. It's a triple-agonist peptide studied Phase 3 for metabolic health — targeting GLP-1, GIP Retatrutide Dosing Schedule: Proven 2026

Mounjaro (tirzepatide): As a dual GLP-1/GIP receptor agonist, it has demonstrated even greater efficacy in weight loss and glycemic control, with emerging evidence of strong cardiovascular protection

However, you should reach out to your PlexusDx provider if sweating is severe, occurs suddenly after weeks of stability, comes with fever or chills, or significantly impacts your sleep or daily life

No prescription required

Record symptoms along with their timing, severity, and relationship to doses, meals, and hydration status

For readers focused on that foundation, the Gut Health supplements collection is a helpful place to explore

FDA submission filed